No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes

byBryan Sun

September 20, 2023

in StudyGraphics

Reading Time: 1 min read

Click to read the study in The New England Journal of Medicine

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

Early anticoagulation after stroke decreases recurrence without increasing bleeding in patients with atrial fibrillation

Combined digital intervention may be effective for osteoarthritis pain

RelatedReports

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization

Cardiology

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

April 9, 2026

2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]

Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026

Intensive rehabilitation not superior to traditional therapy for arm function after stroke

Cardiology

Early anticoagulation after stroke decreases recurrence without increasing bleeding in patients with atrial fibrillation

July 29, 2025

StudyGraphics

#VisualAbstract: Reduced-Dose was Not Non-Inferior to Full-Dose Direct Oral Anticoagulants in Venous Thromboembolism Patients

March 10, 2025

Low free sugar diet reduces hepatic steatosis in nonalcoholic fatty liver disease in adolescent males

Pegozafermin associated with improved outcomes in nonalcoholic steatohepatitis

#VisualAbstract:Oral semaglutide effectively reduces bodyweight in non-diabetic adults with obesity

Migraines associated with an increased risk of cardiovascular events in women

Atogepant may be safe and effective for prevention of chronic migraines

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result